Is Myomo Stock a Good Investment?
Myomo Investment Advice | MYO |
- Examine Myomo's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Myomo's leadership team and their track record. Good management can help Myomo navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Myomo's business and its evolving consumer preferences.
- Compare Myomo's performance and market position to its competitors. Analyze how Myomo is positioned in terms of product offerings, innovation, and market share.
- Check if Myomo pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Myomo's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Myomo Inc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Myomo Inc is a good investment.
Sell | Buy |
Hold
Market Performance | Very Weak | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Myomo Stock
Researching Myomo's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 59.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.16. Myomo Inc last dividend was issued on the 31st of January 2020. The entity had 1:30 split on the 31st of January 2020.
To determine if Myomo is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Myomo's research are outlined below:
| Myomo Inc generated a negative expected return over the last 90 days | |
| Myomo Inc has high historical volatility and very poor performance | |
| The company reported the last year's revenue of 32.55 M. Reported Net Loss for the year was (6.18 M) with profit before taxes, overhead, and interest of 23.19 M. | |
| Myomo Inc has about 5.35 M in cash with (3.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.46. | |
| Myomo Inc has a frail financial position based on the latest SEC disclosures | |
| Roughly 59.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Disposition of 6024 shares by Paul Gudonis of Myomo subject to Rule 16b-3 |
Myomo uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Myomo Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Myomo's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 11th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 11th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Myomo's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Myomo's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-06 | 2024-09-30 | -0.04 | -0.03 | 0.01 | 25 | ||
2024-03-07 | 2023-12-31 | -0.06 | -0.07 | -0.01 | 16 | ||
2023-08-09 | 2023-06-30 | -0.03 | -0.04 | -0.01 | 33 | ||
2025-03-05 | 2024-12-31 | -0.0233 | -0.01 | 0.0133 | 57 | ||
2023-05-10 | 2023-03-31 | -0.13 | -0.11 | 0.02 | 15 | ||
2023-11-07 | 2023-09-30 | -0.09 | -0.06 | 0.03 | 33 | ||
2024-08-06 | 2024-06-30 | -0.07 | -0.03 | 0.04 | 57 | ||
2021-05-05 | 2021-03-31 | -0.66 | -0.57 | 0.09 | 13 |
Myomo Target Price Consensus
Myomo target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Myomo's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 6 | Strong Buy |
Most Myomo analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Myomo stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Myomo Inc, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationMyomo Target Price Projection
Myomo's current and average target prices are 5.48 and 7.67, respectively. The current price of Myomo is the price at which Myomo Inc is currently trading. On the other hand, Myomo's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Myomo Target Price
Myomo Analyst Ratings
Myomo's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Myomo stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Myomo's financials, market performance, and future outlook by experienced professionals. Myomo's historical ratings below, therefore, can serve as a valuable tool for investors.Myomo's market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 182.56 M.Market Cap |
|
Myomo's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.50) | (0.53) | |
| Return On Capital Employed | (0.81) | (0.85) | |
| Return On Assets | (0.50) | (0.53) | |
| Return On Equity | (1.04) | (1.09) |
Determining Myomo's profitability involves analyzing its financial statements and using various financial metrics to determine if Myomo is a good buy. For example, gross profit margin measures Myomo's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Myomo's profitability and make more informed investment decisions.
Evaluate Myomo's management efficiency
Myomo Inc has Return on Asset of (0.1365) % which means that on every $100 spent on assets, it lost $0.1365. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.367) %, meaning that it generated no profit with money invested by stockholders. Myomo's management efficiency ratios could be used to measure how well Myomo manages its routine affairs as well as how well it operates its assets and liabilities. As of the 20th of March 2025, Return On Tangible Assets is likely to drop to -0.53. In addition to that, Return On Capital Employed is likely to drop to -0.85. At this time, Myomo's Total Assets are very stable compared to the past year. As of the 20th of March 2025, Net Tangible Assets is likely to grow to about 7.7 M, while Other Assets are likely to drop about 121.3 K.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.65 | 0.62 | |
| Tangible Book Value Per Share | 0.65 | 0.62 | |
| Enterprise Value Over EBITDA | (16.28) | (17.09) | |
| Price Book Value Ratio | 9.84 | 10.33 | |
| Enterprise Value Multiple | (16.28) | (17.09) | |
| Price Fair Value | 9.84 | 10.33 | |
| Enterprise Value | 125.6 M | 131.8 M |
The strategic vision of Myomo Inc management plays a critical role in its financial performance. By evaluating this vision, we provide insights into the stock's growth potential.
Beta 1.605 |
Basic technical analysis of Myomo Stock
As of the 20th of March, Myomo secures the Mean Deviation of 3.4, insignificant risk adjusted performance, and Standard Deviation of 6.26. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Myomo Inc, as well as the relationship between them.Myomo's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Myomo insiders, such as employees or executives, is commonly permitted as long as it does not rely on Myomo's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Myomo insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Myomo's Outstanding Corporate Bonds
Myomo issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Myomo Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Myomo bonds can be classified according to their maturity, which is the date when Myomo Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MYLAN N V Corp BondUS62854AAP93 | View | |
| MYLAN N V Corp BondUS62854AAN46 | View | |
| MYLAN INC 54 Corp BondUS628530BC02 | View | |
| MYLAN INC 455 Corp BondUS628530BK28 | View | |
| MYLAN INC Corp BondUS628530BJ54 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Understand Myomo's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Myomo's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.08) | |||
| Mean Deviation | 3.4 | |||
| Coefficient Of Variation | (9,016) | |||
| Standard Deviation | 6.26 | |||
| Variance | 39.17 | |||
| Information Ratio | 0.0028 | |||
| Jensen Alpha | 0.005 | |||
| Total Risk Alpha | 0.6096 | |||
| Treynor Ratio | (0.09) | |||
| Maximum Drawdown | 48.26 | |||
| Value At Risk | (6.63) | |||
| Potential Upside | 5.36 | |||
| Skewness | 4.28 | |||
| Kurtosis | 27.82 |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.08) | |||
| Mean Deviation | 3.4 | |||
| Coefficient Of Variation | (9,016) | |||
| Standard Deviation | 6.26 | |||
| Variance | 39.17 | |||
| Information Ratio | 0.0028 | |||
| Jensen Alpha | 0.005 | |||
| Total Risk Alpha | 0.6096 | |||
| Treynor Ratio | (0.09) | |||
| Maximum Drawdown | 48.26 | |||
| Value At Risk | (6.63) | |||
| Potential Upside | 5.36 | |||
| Skewness | 4.28 | |||
| Kurtosis | 27.82 |
Consider Myomo's intraday indicators
Myomo intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Myomo stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Myomo Corporate Filings
| 14th of March 2025 Other Reports | ViewVerify | |
F4 | 13th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 10th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 10th of February 2025 Other Reports | ViewVerify |
Myomo Stock media impact
Far too much social signal, news, headlines, and media speculation about Myomo that are available to investors today. That information is available publicly through Myomo media outlets and privately through word of mouth or via Myomo internal channels. However, regardless of the origin, that massive amount of Myomo data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Myomo news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Myomo relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Myomo's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Myomo alpha.
Myomo Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Myomo can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Myomo Corporate Executives
Elected by the shareholders, the Myomo's board of directors comprises two types of representatives: Myomo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Myomo. The board's role is to monitor Myomo's management team and ensure that shareholders' interests are well served. Myomo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Myomo's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Henry | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myomo. If investors know Myomo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myomo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.16) | Revenue Per Share | Quarterly Revenue Growth 1.537 | Return On Assets | Return On Equity |
The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Myomo's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Myomo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myomo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.